Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen‐HCl–UVA (Intercept™) over a 5‐year period of extensive delivery

Publisher: John Wiley & Sons Inc

E-ISSN: 1423-0410|109|4|414-416

ISSN: 0042-9007

Source: VOX SANGUINIS, Vol.109, Iss.4, 2015-11, pp. : 414-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract